Abstract
Background Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome is a leading cause of death and disease burden. Following this, vertical transmission is the main source of HIV infection on children globally. Morbidity and mortality among HIV-exposed infants are still the main health challenges in Ethiopia. Therefore, the aim of this study was to determine the prevalence of HIV1infection and its associated factors among exposed infants at Shegaw Motta General Hospital, Ethiopia.
Methods Hospital-based cross-sectional study was conducted on exposed infants at Shegaw Motta General Hospital from September 1, 2022 to July 30, 2023. The consecutive convenience sampling technique was used to select study participants. Whole blood sample was collected from mothers and infants. Laboratory tests like early infant diagnosis, cluster of differentiation 4 counts and viral load were performed using standard operating procedure. Then, the data were entered into EpiData version 3.1 and analyzed by SPSS version 20. Finally, bivariable and multivariable logistic regressions were carried out to identify factors significantly associated (P<0.05).
Results Out of 155 infants, about 79(50.9%) infants were females and87(56.1%) was urban resident. Furthermore, majority of infants were born from mothers who could not able to write and read 88(56.8%) and maternal ages range from 25-34years were 138(89.0%). The overall prevalence of HIV1 infection among exposed infants was6(3.87%) with (95%CI: 2.9-8.2). Pregnant women had not antennal care (AOR=7.281, P = 0.001), home delivery (AOR= 3.239, P=0.001), maternal not received antiretroviral prophylaxis (AOR = 9.213, P= 0.001), infants not intake nevirapine prophylaxis (AOR=2.560, P= 0.007) and maternal high viral load (AOR= 5.120, P= 0.004) were the factors associated with HIV infection among exposed infants.
Conclusion The HIV1 infection among exposed infants was still high (3.87%). Pregnant women had not antenatal care follow up, home delivery, maternal high viral load, and not receiving antiretroviral prophylaxis, infant not intake nevirapine prophylaxis increases the risk of HIV1 infection. Therefore, health facilities should strictly strengthen the PMTCT service by providing maternal antiretroviral prophylaxis, infant nevirapine prophylaxis, promoting antenatal care service, early screening maternal viral load and scale up skilled delivery to eliminate HIV infection among exposed infants.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical clearance and permission letter were obtained from Shegaw Motta General Hospital administrative office with reference number (SMGH 534/94/72). Additionally, written consent was obtained from a parent and/or legal guardian of study participants in accordance with the Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
* correspondence author
Abbreviations
- AOR
- adjusted odd ratio
- ART
- Antiretroviral therapy
- ARV
- antiretroviral
- ANC
- Antenatal Care
- COR
- Crude odd ratio
- DNA
- Deoxy-ribose nucleicacid
- EDTA
- ethylenediamine tetra acetylene
- EID
- early infant diagnosis
- HIV
- Human immunodeficiency virus
- NAAT
- nucleic acid amplification
- NVP
- nevirapine
- PCR
- polymerase chain reaction
- PMTCT
- prevention of mother-to child transmission,
- MTCT
- mother to child transmission
- RNA
- ribose nucleic acid
